MétaCan
Menu
Back to cohort
Record W6949684207 · doi:10.5281/zenodo.16575676

Perspectives and Insights on Antineoplastic Agents with Diverse Mechanisms of Action (L01XX): From Development to New Drug Application (NDA) Submission for FDA

2025· article· en· W6949684207 on OpenAlexaboutno aff

Bibliographic record

VenueZenodo (CERN European Organization for Nuclear Research) · 2025
Typearticle
Languageen
FieldMedicine
TopicAdvanced Breast Cancer Therapies
Canadian institutionsnot available
Fundersnot available
KeywordsDrugAction (physics)Drug approvalDrug deliveryAntineoplastic DrugsCancer drugsCancerSite of action

Abstract

fetched live from OpenAlex

Combinations of antineoplastic agents (ATC code L01XY) are critical in modern oncology, leveraging synergistic mechanisms to enhance efficacy against hematologic and solid tumors. These therapies combine cytotoxic, targeted, and immunotherapeutic agents to overcome resistance and improve patient outcomes, addressing the global cancer burden projected to reach 28.4 million cases by 2040. This article reviews the L01XY class’s pharmacology, chemical properties, container closure systems, safety profiles, and emerging technologies, such as nanoparticle delivery and biomarker-driven regimens. It also outlines the regulatory pathway for submitting a New Drug Submission (NDS) to Health Canada, aligning with the Food and Drugs Act, Health Canada regulations, and ICH guidelines. Recommendations emphasize early regulatory engagement, robust pharmacovigilance, and innovative delivery systems to ensure safe, effective, and accessible therapie.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.015
metaresearch head score (Gemma)0.014
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: none
Teacher disagreement score0.020
Threshold uncertainty score0.078

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0150.014
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0020.001
Science and technology studies0.0020.004
Scholarly communication0.0110.007
Open science0.0020.002
Research integrity0.0050.007
Insufficient payload (model declined to judge)0.0200.005

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.028
GPT teacher head0.281
Teacher spread0.253 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueZenodo (CERN European Organization for Nuclear Research)Same topicAdvanced Breast Cancer TherapiesFrench-language works237,207